AstraZeneca’s first-quarter earnings doubled, with its Covid-19 vaccine generating $275 million in revenue. The pharma company’s revenue for the quarter rose 15 percent
Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions a
CEO of AstraZeneca, Pascal Soriot, recently stated that researchers are vehemently working to fish out the ‘winning formula’ to boost the Oxford COVID-19 vaccine. The C
Get upcoming M&A news and updates here at the nation’s fastest-growing CEO magazine, Industry Leaders.
The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes as planned, t
Pharmaceutical behemoth Pfizer has reportedly been in talks for acquisition of Allergan, which could be touted as the biggest acquisition of the year. This acquisition will create